Introduction
Despite decades of research and recent advances in the fields of influenza
vaccines and antivirals, the influenza viruses continue to cause high
levels of morbidity and mortality in the community during each winter
season. Although current attention is focused on the impending challenge
of the introduction of a novel pandemic strain (H5N1) into the human
population [1,2], it has long been recognised that the cumulative effect
of ‘inter-pandemic’ periods of influenza are more significant
in respect of mortality [3]. In this surveillance report, we aimed to
investigate the long term trends of influenza-like illness (ILI) collected
from a sentinel general practice network over the last 40 years in England
and Wales and to assess its changing burden on primary care.
Methods
The Royal College of General Practitioners Weekly Returns Service (WRS)
is a clinical information system based on a national network of sentinel
general practices throughout England and Wales and is best known for
its routine surveillance of respiratory illnesses [4]. Clinical diagnostic
data are recorded by general practitioners (GPs) and stored as Read
codes [5], which are mapped to the International Classification of
Diseases (version 9; ICD-9) for analytical purposes. New episodes of
illness are distinguished from ongoing consultations; new episodes
of recurring or chronic conditions such as asthma are deemed to occur
when exacerbations occur or when the condition is out of control. Currently
(winter 2005/06), the network consists of 94 practices, comprising
approximately 427 GPs, who continually record data on a twice-weekly
basis, covering a patient population of approximately 940 000 (1.6%
of the population of the United Kingdom). The network is representative
of the national population in terms of both urban/rural and socioeconomic
demographic spread [6]. A virological sampling scheme runs concurrently
during the winter season: GPs take a combined nose and throat swab
from a proportion of patients presenting with ILI or an acute respiratory
infection. In collaboration with the Health Protection Agency, swabs
undergo a molecular analysis for currently circulating influenza A
viruses (subtypes H3 and H1), influenza B and respiratory syncytial
virus [7]. This scheme is unique in providing virological validation
of the clinical incidence data and timely information relating to the
antigenicity and genetic composition of the influenza viruses circulating
the community [8]. Swabs taken from this scheme have also been tested
retrospectively to assess the clinical burden of newly discovered pathogens,
e.g., human metapneumovirus, and their contribution to respiratory
morbidity in different age groups [9].
Weekly episode incidence rates of ILI (ICD-9 487) were calculated
for combined male and female and all-ages. GPs in the WRS do
not adhere to strict clinical case definitions of ILI as used
in some other European influenza surveillance systems [10]. It
is routinely accepted, however, that symptoms of ILI are recognised
by the sudden onset of one or more prominent systemic symptoms
including fever, headache, myalgia and malaise, and one or more
respiratory symptoms including cough, coryza, sore throat and
shortness of breath.
Influenza seasons were defined as weeks 40 to 20, that is, a
period from approximately October through to May the following
year. Thresholds used to define levels of ILI activity in the
community are based upon analyses of clinical and virological
data [8,11]. The differing threshold levels of ILI are defined
as: baseline activity (rates of <30 per 100 000); normal seasonal
activity (30-200 per 100 000); above average seasonal activity
(200-400 per 100 000); and epidemic activity (>400 per 100
000).
Results
During the forty years of influenza surveillance, there have been four
discernable winters of high ILI rates [FIGURE]. The highest rates of
ILI were recorded during the winter of 1969/70, peaking at 1252 per
100 000 during week 01. This was followed by a season of low activity
where the peak rate was 144 per 100 000 during week 11 of 1971. During
1972/73 ILI peaked in week 52 (707 per 100 000) but the second highest
seasonal rates were recorded during 1975/76 (789 per 100 000, week
08 1976); this was followed by a season of relatively low activity.
After the 1975/76 season, there were 13 years of moderate activity
until the last substantial epidemic of influenza, which occurred in
1989/90; rates reached a peak of 584 per 100 000 during week 49 of
1989. During the decade following the 1989/90 epidemic, there was moderate
activity, except for the season of 1997/98, when there was an unusually
low season of ILI activity. Following the winter of 1999/2000 there
was low ILI activity; rates did not exceed 81 per 100 000 during any
week within this period. There was evidence of a reducing trend of
ILI which started from the early 1980s and continued through to the
2005/06 season. The last six winters have seen such low activity that
the baseline threshold was reduced accordingly in 2003, from an incidence
rate of 50 to 30 per 100 000 [11].
 Discussion
The WRS was established in 1964 and has archived all data since 1966/67,
providing an unrivalled opportunity to look at long-term trends of
a variety of diseases. In this report we investigated the long term
trends of ILI in England and Wales over a forty year period. The clinical
impact of the 1968/69 pandemic was felt in the UK during the winter
of 1969/70 when the WRS recorded higher rates of ILI than during any
subsequent winter. Although there was much reduced morbidity in the
following season, the next ten years saw sustained high levels of ILI.
It is interesting to note that during the last years of H2N2 circulation
(1966/67 to 1968/69) rates of ILI were relatively high compared to
the rest of the time series. It is important to remember that the H2N2
subtype was introduced into the population during the 1957/58 pandemic
and therefore had been circulating for fewer than ten years when the
WRS first began recording ILI morbidity statistics. The time series
also incorporates the 1977/78 pandemic, when the influenza A H1N1 subtype
was re-introduced and co-circulated with the H3N2 subtype. The clinical
impact of this pandemic was not as great; rates peaked at 351 per 100
000, less than one third of rates recorded during 1969/70, and were
not discernibly higher than any other winter during that decade. During
this pandemic, H1N1 infection was limited to young people; this might
explain why the impact of this pandemic was so clinically understated.
The introduction of a novel influenza subtype into a mainly
immunologically naive population (with the possible exception
of the elderly population who might have had previous exposure
to similar antigenic strains [12]) provides the influenza virus
with the optimal conditions to infect, transmit and thus inflict
high levels of morbidity on the community. Analysis of the figure
reveals that over the years following the winter season of 1980/81,
there was a general reducing trend of ILI, with the exception
of intermittent periods of heightened activity, for example 1989/90.
This may reflect the declining ability of the H3N2 virus to efficiently
infect susceptible hosts. Factors influencing this might include
mutational changes to the virus structure (especially in domains
of the haemagglutinin associated with receptor binding), forced
by decades of immunological pressure from the population. This
could result in a gradual decrease in viral fitness and thus
a virus that is not able to infect and transmit as efficiently
as when first introduced to the population.
If this scenario were true, then we would predict that the H3N2
subtype is making way for another pandemic strain, whether H5N1,
or possibly another subtype from a yet unknown source. From analysis
of our data, we would expect that following the introduction
of a novel pandemic strain, incidence rates of ILI would peak
at extremely high levels during the initial waves of the pandemic,
but would then be sustained for a period of approximately 10
years following its introduction. Potentially, it is this ten
year period that presents more problems to healthcare systems
than the original pandemic waves, as both primary and secondary
healthcare resources would be stretched over much longer periods
of time. This, in combination with an increasingly ageing population,
may present serious problems in the post-pandemic decade. Current
debate revolving around pandemic planning has only considered
the initial herald waves of the pandemic, and not the subsequent
years in the post-pandemic era, which we argue could be equally
important. This report does not advocate changing current pandemic
plans, its aim is rather to raise awareness of the challenges
we face in the post-pandemic decade.
The WRS currently reports incidence rates of ILI in the community
that are very close to baseline threshold levels. The reduction
may also reflect changes in social behaviour: family sizes are
smaller; levels of hygiene have increased; air quality has improved;
smoking has decreased; all might have played a part in reducing
the transmissibility of influenza viruses and thus have contributed
to the reduction of ILI. However, we must not be complacent in
the face of the apparent decline of ILI in recent years, it is
most likely that this is not a result of our attempts to control
the spread of the influenza virus through treatment and prophylaxis;
we must remember that this may simply be the calm before the
storm.
Acknowledgments
We gratefully acknowledge the contribution of the WRS sentinel practices
and their staff to providing the general practitioner episode data.
Dr AJ Elliot is jointly funded by the Royal College of General Practitioners
and Health Protection Agency.
|